Publication | Closed Access

Oral arsenic plus retinoic acid versus intravenous arsenic plus retinoic acid for non-high-risk acute promyelocytic leukaemia: a non-inferiority, randomised phase 3 trial

Hematological MalignancyRetinoic Acid VersusOncologyMixed-phenotype Acute LeukemiaPharmacologyRetinoic AcidHematologyMedicinePhase 3